| Literature DB >> 19656807 |
Masahide Kondo1, Shu-Ling Hoshi, Masakazu Toi.
Abstract
'Cost saving' was suggested in our recent economic evaluation of chemoprevention of breast cancer targeting women at high risk in Japan. However, this budget impact analysis reveals that the introduction of chemoprevention appears to be not budget saving for approximately 20 years, whereas the level of budget impact seems affordable.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19656807 DOI： 10.1093/jjco/hyp081
Source DB: PubMed Journal: Jpn J Clin Oncol ISSN： 0368-2811 Impact factor: 3.019